Chamber-dependent circadian expression of cardiac natriuretic peptides

Jens Peter Goetze1, Birgitte Georg, Henrik L Jørgensen

  • 1Department of Clinical Biochemistry, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark. JPG@dadlnet.dk

Regulatory Peptides
|December 29, 2009
PubMed

Insights

Cardiac natriuretic peptides like atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) protect the heart. This study found that B-type natriuretic peptide (BNP) mRNA levels in the ventricles show significant daily fluctuations, suggesting a role in cardiac disease susceptibility.

Area of Science:

  • Cardiology
  • Chronobiology
  • Molecular Biology

Background:

  • Atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) are crucial for local myocardial protection against fibrosis.
  • Circadian rhythms of cardiac natriuretic peptides may influence cardiac protection against disease.

Purpose of the Study:

  • To investigate diurnal changes in the messenger RNA (mRNA) of ANP, BNP, and their receptor NPR-A in atrial and ventricular myocardium.
  • To correlate these changes with the expression of core clock genes Per1 and Bmal1.

Main Methods:

  • Mice were exposed to either a standard light-dark cycle (Zeitgeber Time, ZT) or constant darkness (Circadian Time, CT).
  • mRNA levels of ANP, BNP, NPR-A, Per1, and Bmal1 were quantified using RT-PCR in atrial and ventricular tissues at various time points.
  • Expression patterns were analyzed under both light-controlled and constant dark conditions.

Main Results:

  • Core clock genes Per1 and Bmal1 exhibited antiphase oscillations in both cardiac chambers.
  • Atrial ANP and NPR-A mRNA showed borderline significant diurnal variations.
  • Ventricular BNP mRNA displayed significant circadian oscillations, with the lowest levels at CT 12.

Conclusions:

  • A distinct chamber-dependent circadian rhythm exists for cardiac BNP mRNA, unlike ANP.
  • The observed circadian pattern of BNP mRNA may be linked to heightened cardiac susceptibility and response to disease.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response01:15

Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response

Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...